United Services Automobile Association’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-217,216
Closed -$4.8M 669
2019
Q2
$4.8M Buy
217,216
+1,950
+0.9% +$33.9K 0.01% 808
2019
Q1
$2.94M Hold
215,266
0.01% 985
2018
Q4
$1.95M Sell
215,266
-15,530
-7% -$180K 0.01% 1063
2018
Q3
$3.81M Sell
230,796
-5,768
-2% -$102K 0.01% 922
2018
Q2
$3.31M Sell
236,564
-2,357
-1% -$33.7K 0.01% 980
2018
Q1
$2.64M Buy
238,921
+6,187
+3% +$67.7K 0.01% 1047
2017
Q4
$2.05M Buy
232,734
+49,442
+27% +$529K 0.01% 1067
2017
Q3
$2.45M Buy
183,292
+24,515
+15% +$324K 0.01% 1002
2017
Q2
$2.28M Buy
+158,777
New +$3.05M 0.01% 997

Other funds holding CHRS

United Services Automobile Association's CHRS Position: Q3 2019 in Review

United Services Automobile Association sold out of Coherus Oncology (CHRS) in Q3 2019, closing a stake of 217,216 shares — an estimated $4.8M sold.

United Services Automobile Association first reported a position in CHRS in Q2 2017 and held it in 9 quarters. The position peaked at $4.8M in Q2 2019. 167 funds tracked by Wall St. Rank hold CHRS as of Q3 2019.

  • United Services Automobile Association reported no remaining Coherus Oncology position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 217,216 Coherus Oncology shares in Q3 2019, an estimated $4.8M.
  • United Services Automobile Association first reported a position in Coherus Oncology in Q2 2017 and held it in 9 quarters.
  • United Services Automobile Association's Coherus Oncology position peaked at $4.8M in Q2 2019.
  • 167 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.